comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Association of glucagon-like peptide-1 receptor in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology Kidney Outcomes With Glucagon-Like Peptide-1
Description
The Lancet, 390 (10103): 16641675
Respondents had an average age of 42.6 years and were 54.4% female, 45.1% male, and 0.5% nonbinary, representing all 50 states and the District of Columbia
But for others, it may not be enough to reach it, says Dr
BMJ (2017) 359:j4849
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population
GLP-1 receptor agonists
